Developers say security testing has uncovered no new serious bugs as Zcash's Ironwood upgrade moves toward testnet activation.

Zcash developer Dev has revealed that the Zcash testnet is being updated for the Ironwood upgrade tomorrow, sparking excitement.

Z.ai has launched ZCode, a free AI coding tool powered by GLM-5.2 that challenges Cursor, Claude Code and GitHub Copilot ...

ABC News medical correspondent Dr. Darien Sutton explains how Tzield works to delay type 1 diabetes progression, who is ...

Z.ai’s GLM-5.2 shows promise in cybersecurity benchmarks, but open-weight deployment raises enterprise security and ...

Look to these tools to improve your AI coding practices and the quality, security, and reliability of your AI-generated code.

Type 1 diabetes destroys beta cells in stages. By Stage 3, the autoimmune attack has already triggered symptomatic high blood sugar and the child has begun insulin therapy. What remains is residual ...

Treatment with teplizumab significantly slowed the decrease in mean C-peptide levels, a marker of beta cell function, compared with placebo. The Food and Drug Administration (FDA) has granted ...

After accepting Sanofi’s application for an expansion of its Type 1 diabetes treatment Tzield and putting it in the fast lane for a potential approval under a controversial new pathway, the FDA has ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Despite some back-and-forth with the U.S. FDA regarding inclusion in the somewhat controversial Commissioner’s National Priority Voucher (CNPV) program, Sanofi SA’s Tzield (teplizumab) gained FDA ...

What Is It, and Why Does It Matter? Tzield (teplizumab-mzwv) is a prescription immune therapy that can help delay the progression of type 1 diabetes (T1D). The FDA has approved Tzield for slowing the ...